Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-06 04:38:23 - browse：79

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Does good food count as health care? Study aims to find out

WSS

What American doctors can learn from their Israeli counterparts

How to protect patients from sexual assault

Medicaid rebukes states for mistakenly disenrolling children

Congress must reauthorize a committee to support older Americans

How to protect patients from sexual assault

Readout LOUD podcast: A CRISPR milestone, biotech mixology

hotspot

Wikipedia

focus

Peter Hotez and the public health issue of online harassment

FDA's Woodcock to retire early next year

Alkermes shareholders re

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

FDA approval of Sarepta Duchenne genetic therapy gives me hope

PBM reforms clear House panel

In Memoriam: Notable people who died in 2023

Stem cell treatment guidelines are released by FDA

knowledge

How to fix cancer clinical trials' diversity problem

Covid hospitalizations on the rise, Humana says

What American doctors can learn from their Israeli counterparts

Hospitals look to new technology to keep health care workers safe

Congress must reauthorize a committee to support older Americans

NIH nominee Bertagnolli will get October confirmation hearing

hotspot

knowledge

explore

hotspot